178 related articles for article (PubMed ID: 25616442)
1. The Endothelium as a Target for the Treatment of Heart Failure.
Yang O; Li J; Kong J
Cell Biochem Biophys; 2015 Jul; 72(3):751-6. PubMed ID: 25616442
[TBL] [Abstract][Full Text] [Related]
2. Enhanced nitric oxide bioavailability in coronary arteries prevents the onset of heart failure in rats with myocardial infarction.
Couto GK; Britto LR; Mill JG; Rossoni LV
J Mol Cell Cardiol; 2015 Sep; 86():110-20. PubMed ID: 26225841
[TBL] [Abstract][Full Text] [Related]
3. TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure.
Kleinbongard P; Heusch G; Schulz R
Pharmacol Ther; 2010 Sep; 127(3):295-314. PubMed ID: 20621692
[TBL] [Abstract][Full Text] [Related]
4. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
5. Cytoprotective pathways in the vascular endothelium. Do they represent a viable therapeutic target?
Mason JC
Vascul Pharmacol; 2016 Nov; 86():41-52. PubMed ID: 27520362
[TBL] [Abstract][Full Text] [Related]
6. Redox-sensitive mechanisms underlying vascular dysfunction in heart failure.
Konradi J; Mollenhauer M; Baldus S; Klinke A
Free Radic Res; 2015 Jun; 49(6):721-42. PubMed ID: 25788126
[TBL] [Abstract][Full Text] [Related]
7. Heart failure with preserved ejection fraction: Defining the function of ROS and NO.
Zuo L; Chuang CC; Hemmelgarn BT; Best TM
J Appl Physiol (1985); 2015 Oct; 119(8):944-51. PubMed ID: 25977452
[TBL] [Abstract][Full Text] [Related]
8. Endothelial dysfunction, arterial stiffness, and heart failure.
Marti CN; Gheorghiade M; Kalogeropoulos AP; Georgiopoulou VV; Quyyumi AA; Butler J
J Am Coll Cardiol; 2012 Oct; 60(16):1455-69. PubMed ID: 22999723
[TBL] [Abstract][Full Text] [Related]
9. Inflammation and endothelial dysfunction as therapeutic targets in patients with heart failure.
Tousoulis D; Charakida M; Stefanadis C
Int J Cardiol; 2005 Apr; 100(3):347-53. PubMed ID: 15837076
[TBL] [Abstract][Full Text] [Related]
10. Secondary endothelial dysfunction: hypertension and heart failure.
Boulanger CM
J Mol Cell Cardiol; 1999 Jan; 31(1):39-49. PubMed ID: 10072714
[TBL] [Abstract][Full Text] [Related]
11. Endothelial dysfunction and heart failure.
Ferrari R; Bachetti T
Ital Heart J; 2001 Sep; 2 Suppl 3():45S-47S. PubMed ID: 11593933
[No Abstract] [Full Text] [Related]
12. Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities.
Thomas SR; Witting PK; Drummond GR
Antioxid Redox Signal; 2008 Oct; 10(10):1713-65. PubMed ID: 18707220
[TBL] [Abstract][Full Text] [Related]
13. A contemporary view on endothelial function in heart failure.
Shantsila E; Wrigley BJ; Blann AD; Gill PS; Lip GY
Eur J Heart Fail; 2012 Aug; 14(8):873-81. PubMed ID: 22677484
[TBL] [Abstract][Full Text] [Related]
14. Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches.
Tousoulis D; Simopoulou C; Papageorgiou N; Oikonomou E; Hatzis G; Siasos G; Tsiamis E; Stefanadis C
Pharmacol Ther; 2014 Dec; 144(3):253-67. PubMed ID: 24928320
[TBL] [Abstract][Full Text] [Related]
15. [Endothelial function in coronary atherosclerosis and heart failure--the role of nitric oxide in regulation of vasomotor tone].
Andreassen AK; Kirkebøen KA
Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4066-9. PubMed ID: 10613099
[TBL] [Abstract][Full Text] [Related]
16. Heart failure, redox alterations, and endothelial dysfunction.
López Farré A; Casado S
Hypertension; 2001 Dec; 38(6):1400-5. PubMed ID: 11751725
[TBL] [Abstract][Full Text] [Related]
17. Antioxidants and vascular health.
Bielli A; Scioli MG; Mazzaglia D; Doldo E; Orlandi A
Life Sci; 2015 Dec; 143():209-16. PubMed ID: 26585821
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of endothelial dysfunction: from nitric oxide synthesis to ADMA inhibition.
Bermúdez V; Bermúdez F; Acosta G; Acosta A; Añez J; Andara C; Leal E; Cano C; Manuel V; Hernández R; Israili Z
Am J Ther; 2008; 15(4):326-33. PubMed ID: 18645335
[TBL] [Abstract][Full Text] [Related]
19. Ramipril improves nitric oxide availability in hypertensive rats with failing hearts after myocardial infarction.
Linz W; Itter G; Dobrucki LW; Malinski T; Wiemer G
J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):180-5. PubMed ID: 14608524
[TBL] [Abstract][Full Text] [Related]
20. Protective Effects of Glucagon-like Peptide 1 on Endothelial Function in Hypertension.
Liu L; Liu J; Huang Y
J Cardiovasc Pharmacol; 2015 May; 65(5):399-405. PubMed ID: 25384196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
